Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
ATROPINE SULFATE
International Medication Systems (UK) Ltd
A03BA; A03BA01
ATROPINE SULFATE
100 microgram(s)/millilitre
Solution for injection
Product subject to prescription which may not be renewed (A)
Belladonna alkaloids, tertiary amines; atropine
Not marketed
1977-09-08
Read all of this leaflet carefully Please note this medicine is mainly used in emergency situations in which case the doctor will have decided that you needed it. It is unlikely, therefore, that you will have read this leaflet before the medicine was administered to you. - Keep this leaflet. You may need to read it again - If you have any further questions, ask the doctor or nurse - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours - If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell the doctor or nurse. In this leaflet: 1. What Atropine Injection BP Minijet is and what it is used for 2. Before or after you are given Atropine Injection BP Minijet 3. How to use Atropine Injection BP Minijet 4. Possible side effects 5. How to store Atropine Injection BP Minijet 6. Further information. 1. What Atropine Injection BP Minijet is and what it is used for Your medicine is called Atropine Injection BP Minijet. Atropine is an antimuscarinic. It temporarily blocks some nerve endings. This stops glands secreting, makes some muscles (such as in the gut) relax and speeds up the heart. This medicine is used for: • Pre-medication before an anaesthetic to dry the mouth and throat before surgery • During anaesthetic it is used to prevent a slow heart rate and restore blood pressure. • To treat a very slow heart beat • To treat a heart attack • To treat poisoning from insecticides, nerve gas or poisonous mushrooms • To control the side effects of neostigmine (a medicine which increases nerve impulses to the muscles). • As part of an emergency procedure to manually maintain brain function after a heart attack. It is used to treat a slow heart beat occurring with low blood pressure, decreased blood flow or an irregular heart rate. 2. Before or after you are given Atropine Injection BP Minijet You should not be given Atropine if you suffer from any of the following: • Reflux Przeczytaj cały dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Atropine Injection BP Minijet 100 microgram/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1ml contains 0.1 mg atropine sulfate. Each 5ml contains 0.5 mg atropine sulfate; each 10ml contains 1mg atropine sulfate; each 30 ml contains 3mg atropine sulfate. Excipients: also includes sodium, not more than 0.22 mmol per 1ml. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Injection A clear, colourless solution is contained in a USP Type 1 glass vial with an elastomeric closure. The container is specially designed for use with the IMS Minijet injector supplied. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Acute myocardial infarction with AV conduction block due to excess vagal tone (Wenkebach Type I, second-degree AV block) and sinus bradycardia, with associated hypotension and increased ventricular irritability. Atropine can also be used in cardiopulmonary resuscitation for the treatment of sinus bradycardia accompanied by hypotension, hypoperfusion or ectopic arrhythmias. Parenteral atropine is indicated as an antisialogogue in anaesthetic premedication to prevent or reduce secretions of the respiratory tract. During anaesthesia, atropine may be used to prevent reflex bradycardia and restore cardiac rate and arterial pressure resulting from increased vagal activity associated with laryngoscopy, tracheal intubation and intra-abdominal manipulation. It may also be administered to block muscarinic effects when neostigmine is used to counteract muscle relaxants such as tubocurarine. Parenteral atropine is an antidote for cardiovascular collapse following overdose of anticholinesterases; in the treatment of poisoning from organophosphorous insecticides or from chemical warfare 'nerve' gases and in the treatment of mushroom poisoning. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS, CHILDREN OVER 30KG AND THE ELDERLY: Bradyarrhythmias: intramuscular or intravenous 300 to 600 mcg (0.3 to 0. Przeczytaj cały dokument